Company

Incannex Healthcare Limited

Headquarters: Melbourne, VIC, Australia

Employees: 3

CEO: Mr. Joel Bradley Latham

ASX: IHL

Market Cap

A$174.6 Million

AUD as of July 1, 2023

US$116.3 Million

Market Cap History

Incannex Healthcare Limited market capitalization over time

Evolution of Incannex Healthcare Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Incannex Healthcare Limited

Detailed Description

Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Incannex Healthcare Limited has the following listings and related stock indices.


Stock: ASX: IHL wb_incandescent

Details

Headquarters:

Rialto South Tower

Level 39 525 Collins Street

Melbourne, VIC 3000

Australia

Phone: 61 4 2570 3805